alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                                            5
<MULTIPLIER>                                      1000

<S>                             <C>
<PERIOD-TYPE>                   Year
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                           3,685
<SECURITIES>                                         0
<RECEIVABLES>                                   77,964
<ALLOWANCES>                                         0
<INVENTORY>                                     20,803
<CURRENT-ASSETS>                               109,815
<PP&E>                                          49,962
<DEPRECIATION>                                 (32,842)
<TOTAL-ASSETS>                                 149,191
<CURRENT-LIABILITIES>                           83,742
<BONDS>                                         14,867
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         6,432
<OTHER-SE>                                      37,084
<TOTAL-LIABILITY-AND-EQUITY>                   149,191
<SALES>                                        506,012
<TOTAL-REVENUES>                               506,012
<CGS>                                          465,273
<TOTAL-COSTS>                                  465,273
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 948
<INCOME-PRETAX>                                 (9,241)
<INCOME-TAX>                                    (1,077)
<INCOME-CONTINUING>                             (8,164)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (8,164)
<EPS-BASIC>                                      (1.00)
<EPS-DILUTED>                                    (1.00)



</TABLE>
Slip Op. 15-75 

UNITED STATES COURT OF INTERNATIONAL TRADE

TYCO FIRE PRODUCTS L.P.,

 Plaintiff, 

v.

UNITED STATES, 

 Defendant. 

Before: Jane A. Restani, Judge 

Court No. 08-00194 

JUDGMENT

This case having been duly submitted for decision; and the court, after due deliberation, 

having rendered a decision herein; now therefore, in conformity with the decision issued in Court 

No. 08-00190, Slip Op. 15-74, it is hereby

 ORDERED, ADJUDGED, and DECREED that Defendant United States’ Cross-Motion 

for Summary Judgment is GRANTED and Plaintiff Tyco Fire Products L.P.’s Motion for 

Summary Judgment is DENIED. Customs’ classification of the subject merchandise under 

subheading 7020.00.60, HTSUS, is sustained. 

 /s/ Jane A. Restani 

 Jane A. Restani 

 Judge 

Dated: July 10, 2015

 New York, New York
EX-10.2



 Exhibit 10.2 
 AMENDMENT TO EMPLOYMENT AGREEMENT 
 This Amendment to the Employment
Agreement (the “Employment Agreement”), effective as of August 1, 2010, and amended on October 1, 2010 and May 26, 2011, by and between Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and
Vaughan Clift, M.D. (the “Executive”) is made as of July 15, 2013 (“Amendment Date”). 

WHEREAS, the Company and the Executive (together the “Parties”) entered into the Employment Agreement; 

WHEREAS, the Company and the Executive desire to extend the term of the Employment Agreement through July 31, 2014; and

 WHEREAS, the Parties have agreed to modify the Employment Agreement. 

NOW, THEREFORE, the Parties agree as follows: 
 1. The first sentence of Section 1 of the Employment Agreement shall be replaced in its entirety with the following sentence: 
 “The Company hereby agrees to employ Employee and Employee hereby accepts such employment with the Company for the period of 48 months beginning on the Effective Date.” 

2. All other provisions of the Employment Agreement shall remain in full force and effect. 

3. In connection with the Amendment and subject to the approval of the Compensation Committee of the Company, the Company hereby agrees
to grant to the Executive an option to purchase 170,000 shares of the Company’s Common Stock, 85,000 shares of which will vest on the date of grant and 85,000 shares of which will vest on the one year anniversary of the date of grant.

 IN WITNESS WHEREOF, the parties hereby have executed this Amendment as of the Amendment Date written above.

  

			
	AMPIO PHARMACEUTICALS, INC.
	
	 /s/ Michael Macaluso

	By:	 	Michael Macaluso
	Its:	 	CEO
	
	VAUGHAN CLIFT, M.D.
	
	 /s/ Vaughan Clift

	 Vaughan Clift, M.D.
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000833526
<NAME> GEODYNE ENERGY INCOME LTD. PARTNERSHIP II-D
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                         595,297
<SECURITIES>                                         0
<RECEIVABLES>                                  612,534
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,207,831
<PP&E>                                      19,636,152
<DEPRECIATION>                              15,893,129
<TOTAL-ASSETS>                               5,813,993
<CURRENT-LIABILITIES>                          206,972
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   5,340,239
<TOTAL-LIABILITY-AND-EQUITY>                 5,813,993
<SALES>                                      3,144,982
<TOTAL-REVENUES>                             3,264,974
<CGS>                                                0
<TOTAL-COSTS>                                1,903,328
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              1,361,646
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,361,646
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,361,646
<EPS-PRIMARY>                                     4.04
<EPS-DILUTED>                                        0
        

</TABLE>
**Exhibit 32.1**

Certifications Pursuant to Section    906 of the Sarbanes-Oxley Act of 2002(18 U.S.C.  Section 1350)

In connection with the Quarterly    Report of mPhase Technologies, Inc., a New Jersey corporation (the “Company”),    on Form 10Q/A for the quarter ended March 31, 2003, as filed with the Securities    and Exchange Commission (the “Report”), I,  Ronald A. Durando,    Chief Executive Officer of the Company certify, pursuant to Section 906 of    the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that to his knowledge:

|  | (1)    | The Report fully complies with the requirements of Section 13(a)  or 15(d) of the Securities Exchange Act of 1934; and                               |
|--|--------|------------------------------------------------------------------------------------------------------------------------------------------------------|
|  |   |                                                                                                                                                 |
|  | (2)    | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

/s/ Ronald A. DurandoRonald A. DurandoChief Executive Officer

January 26, 2004

----
# Multimedia About Clinical Research and Trials

75th Anniversary Depression: The Case for Ketamine

Technical Assistance Webinar: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)

Director’s Innovation Speaker Series: Transformative Research Requires Insider Researchers

What is informed consent?

Severe Irritability 

The View of the NIMH Intramural Program From the Top: An Interview with Dr. Susan Amara

What are the risks and benefits of participating in clinical research?

What are the different types of clinical research?

What is a blood draw?

What is an MRI? 

What is Clinical Research?

Introduction to the MRI Scanner

Join a Study - Depression, TMS, Psychotherapy and Brain Function

Join a Research Study

Join a Research Study

Teen Depression Study - 3

Treatment Targets, Target Engagement, And Target Populations in Mental Health Services Research to Improve Public Health: Examples from The Field
#### In the Matter of Shawn G. Granger, Respondent, v Danielle D. Misercola, Appellant.

Submitted December 3, 2012;

decided December 11, 2012

Motion for a stay granted.
II 

111TH CONGRESS 

2D SESSION S. 3372 

To modify the date on which the Administrator of the Environmental Protection Agency and applicable States may require permits for discharges 

from certain vessels. 

IN THE SENATE OF THE UNITED STATES 

MAY 13, 2010 

Mrs. BOXER (for herself, Ms. MURKOWSKI, Mrs. MURRAY, Ms. CANTWELL, 

Mr. NELSON of Florida, Mr. WHITEHOUSE, Mr. BEGICH, Mr. INHOFE, 

Ms. LANDRIEU, Mr. VITTER, Ms. SNOWE, and Mr. COCHRAN) introduced 

the following bill; which was read twice and referred to the Committee 

on Environment and Public Works 

A BILL 

To modify the date on which the Administrator of the Environmental Protection Agency and applicable States may 

require permits for discharges from certain vessels. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DISCHARGES INCIDENTAL TO NORMAL OPER4 ATION OF VESSELS. 

5 Section 2(a) of Public Law 110–299 (33 U.S.C. 1342 

6 note) is amended by striking ‘‘during the 2-year period 

7 beginning on the date of enactment of this Act’’ and inVerDate Mar 15 2010 03:42 May 14, 2010 Jkt 089200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S3372.IS S3372

smartinez on DSKB9S0YB1PROD with BILLS
2 

•S 3372 IS

1 serting ‘‘during the period beginning on the date of the 

2 enactment of this Act and ending on December 18, 2013’’. 

Æ 


smartinez on DSKB9S0YB1PROD with BILLS
Exhibit 32.1





Certifications of CEO and CFO Pursuant
to 18 U.S.C. Section 1350,


as Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002





In connection with the Quarterly Report
on Form 10-Q of Houston Wire & Cable Company (the “Corporation”) for the
fiscal quarter endedMarch
31, 2009 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), Charles A.
Sorrentino, as Chief Executive Officer of the Corporation, and Nicol G. Graham,
as Chief Financial Officer of the Corporation, each hereby certifies, pursuant
to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002, to the best of his knowledge,
that:





(1)
            The Report fully complies with the
      requirements of section 13(a) or 15(d) of the Securities Exchange Act of
      1934; and





(2)
            The information contained in the
      Report fairly presents, in all material respects, the financial condition
      and results of operations of the
  Corporation.





Date:   August 4,
      2009
                    /s/ Charles A.
      SorrentinoCharles A.
      SorrentinoChief Executive
      OfficerDate:   August 4,
      2009
                    /s/ Nicol G.
      GrahamNicol G.
    GrahamChief Financial
      Officer





This certification accompanies the
Report pursuant to section 906 of the Sarbanes-Oxley Act of 2002 and shall not
be deemed filed by Houston Wire & Cable Company for purposes of section 18
of the Securities Exchange Act of 1934, as amended.
Exhibit 32.2



CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER 
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Brekford International Corp. (the Company) on Form 10-Q for the three and nine months ended September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Ryan E. Kirch, Principal Financial Officer, certify to my knowledge and in my capacity as an officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                       |                            
|---------------------- | ---------------------------
|Date: October 31, 2008 | /s/ RYANE. KIRCH           
|                       | Ryan E. Kirch              
|                       | Principal Financial Officer
|                       |                            
|                       |                            



The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code) and is not being filed as part of the Report or as a separate disclosure document.
This disposition is not appropriate for publication and is not precedent *

except as provided by 9th Cir. R. 36-3.

The panel unanimously concludes this case is suitable for decision **

without oral argument. See Fed. R. Appellant. P. 34(a)(2).

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA,

 Plaintiff - Appellee,

 v.

JUAN-MANUEL GUTIERREZ-PINEDA,

 Defendant - Appellant.

No. 11-10126

D.C. No. 4:10-cr-00879-DCB

MEMORANDUM* 

Appeal from the United States District Court

for the District of Arizona

David C. Bury, District Judge, Presiding

Submitted January 17, 2012** 

Before: LEAVY, TALLMAN, and CALLAHAN, Circuit Judges.

Juan-Manuel Gutierrez-Pineda appeals from the 51-month sentence imposed

following his conviction for reentry after deportation, in violation of 8 U.S.C.

§ 1326. We have jurisdiction under 28 U.S.C. § 1291, and we affirm.

FILED

JAN 27 2012

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 11-10126

Gutierrez-Pineda contends that the district court procedurally erred by

failing to appreciate its discretion, under Kimbrough v. United States, 552 U.S. 85

(2007), to deviate from the advisory sentencing Guidelines based on policy

differences with the Guidelines, and by failing to adequately address

Gutierrez-Pineda’s objections to the sixteen-level sentencing enhancement

pursuant to U.S.S.G. § 2L1.2(b)(1)(A). These contentions are belied by the record.

Gutierrez-Pineda also contends that the sentence is substantively

unreasonable under United States v. Amezcua-Vasquez, 567 F.3d 1050 (9th Cir.

2009), because the sentence does not adequately account for the age of his prior

convictions, his individual circumstances, and an amendment to the Guidelines that

had not yet been adopted. In light of the totality of the circumstances and the

section 3553(a) sentencing factors, the sentence is substantively reasonable. See

Gall v. United States, 552 U.S. 38, 51 (2007); United States v. Ruiz-Apolonio, 657

F.3d 907, 917-18 (district court not required to consider Guidelines amendment

that has been promulgated but not yet adopted).

AFFIRMED.
Exhibit 4.3







 


Consent of Independent Registered
Public Accounting Firm


We consent to the
reference made to our firm under the caption “Independent Registered Public Accounting Firm” in Part B of the Prospectus
and to the use of our report dated July 18, 2013, in this Registration Statement (Form S-6 No. 333-188083) of Smart Trust, Zacks
Diversified Equity & Corporate Bond Trust, Series 3.


 


/s/ Grant
Thornton LLP


Grant
Thornton LLP


Chicago, Illinois


July 18, 2013
Exhibit 32.2





CERTIFICATION OF PRINCIPAL FINANCIAL
OFFICER REGARDING PERIODIC REPORT CONTAINING 
FINANCIAL STATEMENTS



I, Paul E. Martin, the Principal Financial Officer of Enstar Income/Growth Program Six-A, L.P. (the "Partnership") in compliance with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, hereby certify that, the Partnership's Quarterly Report on Form 10-Q for the six months ended June 30, 2004 (the "Report") filed with the Securities and Exchange Commission:

- fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
- the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.

/s/  Paul E. MartinPaul E. MartinPrincipal Financial OfficerAugust 18, 2004
[Federal Register Volume 74, Number 117 (Friday, June 19, 2009)]
[Notices]
[Page 29263]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14418]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Office of the Secretary


Application of Air Excursions, LLC for Certificate Authority

AGENCY: Department of Transportation.

ACTION: Notice of Order to Show Cause (Order 2009-6-11), Docket DOT-
OST-2008-0318.

-----------------------------------------------------------------------

SUMMARY: The Department of Transportation is directing all interested 
persons to show cause why it should not issue an order finding Air 
Excursions, LLC, fit, willing, and able to engage in interstate 
scheduled air transportation of persons, property, and mail.

DATES: Persons wishing to file objections should do so no later than 
June 26, 2009.

ADDRESSES: Objections and answers to objections should be filed in 
Docket DOT-OST-2008-0318 and addressed to U.S. Department of 
Transportation, Docket Operations, (M-30, Room W12-140), 1200 New 
Jersey Avenue, SE., West Building Ground Floor, Washington, DC 20590, 
and should be served upon the parties listed in Attachment A to the 
Order to Show Cause.

FOR FURTHER INFORMATION CONTACT: Lauralyn J. Remo, Chief, Air Carrier 
Fitness Division (X-56, Room W86-307), U.S. Department of 
Transportation, 1200 New Jersey Avenue, SE., Washington, DC 20590, 
(202) 366-9721.

    Dated: June 12, 2009.
Christa Fornarotto,
Acting Assistant Secretary for Aviation and International Affairs.
[FR Doc. E9-14418 Filed 6-18-09; 8:45 am]
BILLING CODE P
Skip to main content

          -  U.S. Department of Health & Human Services 

            - Virtual Tour
            - Staff Directory
            - En Español

## Site Menu

-  Home 
-  Health Information  - Health Care Providers & Facilities
- Health Info Lines
- HealthCare.gov
- Science Education Resources
- NIH Clinical Research Trials and You
- Talking to Your Doctor

More »

Search Health Topics

Quick Links
- MedlinePlus Health Info
- NIH News in Health
- Wellness Toolkits
 
-  Grants & Funding  - Grants Home Page
- Find Funding
- Due Dates
- How to Apply
- About Grants
- Policy & Compliance
- Grants News/Blog
- Contracts
- Loan Repayment

More »

Quick Links
- RePORT
- eRA Commons
- NIH Common Fund
 
-  News & Events  - News Releases
- Digital Media Kits
- Media Resources
- Media Contacts
- Images and B-roll
- Events
- Social Media

More »

Quick Links
- NIH News in Health
- NIH Research Matters
- NIH Record
 
-  Research & Training  - Medical Research Initiatives
- Science Highlights
- Science Education
- Research in NIH Labs & Clinics
- Training Opportunities
- Library Resources
- Research Resources
- Clinical Research Resources
- Safety, Regulation and Guidance

More »

Quick Links
- PubMed
- Stem Cell Information
- OppNet
- NIDB
- NIH Blueprint for Neuroscience Research
 
-  Institutes at NIH  - List of Institutes and Centers
- NIH Office of the Director
- Directors of NIH Institutes and Centers
- NIH Institute and Center Contact Information

More »

Quick Links
- NCI
- NEI
- NHLBI
- NHGRI
- NIA
- NIAAA
- NIAID
- NIAMS
- NIBIB
- NICHD
- NIDCD
- NIDCR
- NIDDK
- NIDA
- NIEHS
- NIGMS
- NIMH
- NIMHD
- NINDS
- NINR
- NLM
- CC
- CIT
- CSR
- FIC
- NCATS
- NCCIH
 
-  About NIH  - Who We Are
- What We Do
- Jobs at NIH
- Visitor Information
- Frequently Asked Questions
- Contact Us

More »

Quick Links
- The NIH Director
- Take the Virtual Tour
- NIH…Turning Discovery Into Health®
- Impact of NIH Research
- Science, Health, and Public Trust
 

## You are here

Home

# virtual-tour-screenshot-square.jpg

###     Media Folder  

about-nih

###     Title  

###     Description  

OD

###     Site_Section  

About NIH

###     Alt Text  

## Connect with Us

              - Contact Us
              - X
              - Facebook
              - Instagram
              - YouTube
              - Flickr
              - More Social Media from NIH

## Footer

- NIH Home
- Virtual Tour
- En Español
- Visitor Information
- Frequently Asked Questions
- Privacy Policy
- Disclaimers
- Accessibility
- NIH Website Archives

- Nondiscrimination Notice
- Freedom of Information Act
- No Fear Act
- HHS Vulnerability Disclosure
- Office of Inspector General
- USA.gov

NIH…Turning Discovery Into Health®

National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892

U.S. Department of Health and Human Services

Back to Top